Treb schreef op 28 november 2015 22:19:
@Quae nocent, docent:
in de usa zijn de pharma lui en investeerders zeker niet achterlijk en gaan inderdaad niet op hun handen zitten.
Ze starten simpelweg een geheel nieuw bedrijf en direct op nationale schaal.
Geheel vrij van inefficiënte en ineffectieve werkprocessen en werknemers. Ook vrij van verdenkingen als fraude en dergelijke en leeglopen op advocaten.
www.quvapharma.com/index.html"QuVa Pharma, Inc. is a newly-formed national platform for sterile compounding pharmacy services led by two experienced industry executives that has received a majority equity commitment from Bain Capital Private Equity to support the company’s creation and expansion plans. As part of its formation, QuVa Pharma has acquired the assets of the compounding services division of a company leader in the field of parenteral and management services, including its state-of-the-art 503B manufacturing facility in Sugar Land, Texas.
The modern manufacturing facility provides high-quality, ready-to-use compounded sterile preparations to hospitals across the country. Built to meet the most stringent state and federal regulations, the facility is registered with the U.S. Food and Drug Administration (FDA) as an Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act. QuVa Pharma will leverage the resources and healthcare investment experience of Bain Capital Private Equity to expand its current operations and open additional locations. "